BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion-Reference-Cited by-同舟云学术

BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion

Published:2023-09 Issue:3 Volume:3 Page:100302
ISSN:2666-9145
Container-title:Ophthalmology Science
language:en
Short-container-title:Ophthalmology Science

Author:

Hattenbach Lars-Olof,Abreu Francis,Arrisi Pablo,Basu Karen,Danzig Carl J.,Guymer Robyn,Haskova Zdenka,Heier Jeffrey S.,Kotecha Aachal,Liu Ying,Loewenstein Anat,Seres András,Willis Jeffrey R.,Wykoff Charles C.,Paris Liliana P.

Funder

F Hoffmann-La Roche Ltd

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Ophthalmology

Reference44 articles.

1. Retinal vein occlusion review;Ip;Asia Pac J Ophthalmol (Phila),2018

2. Retinal vascular occlusions;Scott;Lancet,2020

3. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors;Song;J Glob Health,2019

4. The burden of disease of retinal vein occlusion: review of the literature;Laouri;Eye (Lond),2011

5. Management of macular edema due to central retinal vein occlusion - the role of aflibercept;Rhoades;Taiwan J Ophthalmol,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Assessment of OCT, Multimodal Imaging, and Cytokine Markers for Predicting Treatment Responses in Retinal Vein Occlusion Associated Macular Edema: A Comparative Review of Anti-VEGF and Steroid Therapies;Diagnostics;2024-09-07

2. Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion;Ophthalmology;2024-08

3. The protective effect of anti-VEGF-A/Ang-2 bispecific antibody on retinal vein occlusion model mice;European Journal of Pharmacology;2024-08

4. Faricimab maintains substance integrity and sterility after compounding and storage in two different polypropylene syringe types;2024-04-29

5. A pivotal decade for bispecific antibodies?;mAbs;2024-03-11